Autologous dendritic cell vaccination (DCVAC/PCa) added to docetaxel chemotherapy in a double-blind, randomized phase III trial (VIABLE) in men with advanced (mCRPC) prostate cancer.
/in Dendritic Cells, International Publications, Prostate Cancer /von 2015-05-30 / J Clin Oncol 33, 2015 (suppl; abstr TPS5070)Phase II randomized trial of autologous tumor lysate dendritic cell vaccine (ADC) plus best supportive care (BSC) compared with BSC, in pre-treated advanced colorectal cancer patients.
/in Colorectal Cancer, Dendritic Cells, International Publications /von 2015-05-30 / J Clin Oncol 33, 2015 (suppl; abstr 3048)Long-term follow-up of patients with acute myelogenous leukemia receiving an autologous telomerase-based dendritic cell vaccine.
/in Acute Leukemia, Dendritic Cells, International Publications /von 2015-05-30 / J Clin Oncol 33, 2015 (suppl; abstr 7007)Dendritic Cell-Based Vaccines that Utilize Myeloid Rather than Plasmacytoid Cells Offer a Superior Survival Advantage in Malignant Glioma
/in Dendritic Cells, Glioblastoma, International Publications /von 2015-05-29 / J. Immunol. 2015 Jul;195(1):367-76A study of mature alpha-DC-1 vaccine to induce immune responses in ovarian cancer.
/in Dendritic Cells, International Publications, Ovarian Cancer /von 2015-05-29 / J Clin Oncol 33, 2015 (suppl; abstr e14033)Long-term survival of a breast cancer patient with extensive liver metastases upon immune and virotherapy: a case report
/in Breast Cancer, Dendritic Cells, Hyperthermia, International Publications, IOZK Veröffentlichungen, Newcastle Disease Virus /von 2015-05-28 / Immunotherapy 2015;7(8):855-60Gastric cancer and the epoch of immunotherapy approaches
/in Dendritic Cells, Gastric Cancer, International Publications /von 2015-05-21 / World J. Gastroenterol. 2015 May;21(19):5778-93Dendritic cell-based vaccination in cancer: therapeutic implications emerging from murine models
/in Dendritic Cells, International Publications /von 2015-05-20 / Front Immunol 2015;6:243Advances in the understanding of cancer immunotherapy
/in Dendritic Cells, International Publications /von 2015-05-18 / BJU Int. 2015 Sep;116(3):321-9
IMMUN-ONKOLOGISCHES ZENTRUM KÖLN
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de